Comparing Drying Options for Sensitive Biologic Projects

Which Drying Method Is Right for Your Formulation? 

As biologics continue to play an increasingly important role in modern pharmaceutical development, selecting the right drying and preservation method is critical to maintaining product stability, efficacy, and shelf life. 

Lyophilization, commonly known as freeze drying, has become one of the most widely adopted preservation techniques across the pharmaceutical and biotechnology industries. The process removes water from a frozen product under vacuum conditions, allowing ice to transition directly from a solid to a vapor without passing through the liquid phase. This helps preserve sensitive biological materials while significantly extending product stability and storage life. 

As pharmaceutical products become more complex and global supply chains continue to expand, manufacturers are increasingly exploring different drying technologies. While traditional freeze drying remains the industry standard for sensitive biologics, alternative approaches such as spray drying and novel formats such as lyobeading may offer advantages depending on the formulation and application. 

Freeze Drying 

Freeze drying is the most established and widely used form of stabilization method for final product presentations within the biopharmaceutical industry. It is used across a broad range of pharmaceutical formulations, vaccines, laboratory reagents, and sensitive biologics. 

The process offers precise control of temperature and vacuum conditions, helping to minimize the risk of product collapse and other temperature-related changes that can affect stability and product quality. This careful balance is essential for maintaining efficacy, viability, and long-term performance throughout the drying cycle. 

How Freeze Drying Works 

The process begins by freezing the formulation, which determines the structure of the ice crystals within the product. 

The frozen product is then placed under vacuum conditions, where primary drying occurs. During this stage, unbound water is removed through sublimation, allowing ice to transition directly into vapor. 

Secondary drying follows, removing bound water molecules and reducing moisture content to a predetermined level. Additional energy is applied during this stage, with product temperatures typically increasing to between 20°C and 30°C. 

Freeze drying is commonly performed with products already filled into vials or containers, with stoppers often being applied within the freeze dryer itself to help minimize the risk of contamination. The process results in a dry, porous "cake" structure at the bottom of the vial, which can be readily reconstituted prior to use. 

LyoBeads 

Lyobeads are an advanced freeze-drying technique in which liquid formulations are dispensed into small droplets before undergoing lyophilization. 

Unlike conventional freeze drying, which produces a solid cake within a vial, this process creates free-flowing dried beads that are easy to store, transport, and reconstitute. The technology is becoming increasingly popular within the biopharmaceutical and diagnostic sectors due to its ability to provide excellent stability, dose uniformity, and product consistency. 

How Lyobeads Works 

The formulation is first prepared using carefully selected excipients and stabilizers to protect the product during freezing and drying. 

The liquid is then dispensed into controlled droplets, typically onto a cold surface or into a cryogenic liquid such as liquid nitrogen. This rapid freezing process creates uniform beads while preserving biological structure and activity. 

The frozen beads then undergo primary drying under vacuum conditions to remove unbound moisture through sublimation. Secondary drying follows to remove residual moisture and achieve the desired moisture content. 

The result is a stable, free-flowing lyophilized bead with excellent reconstitution properties and long-term stability. 

Spray Drying 

Although spray drying is not a form of lyophilization, it is a widely used drying technology that is often considered alongside freeze drying for pharmaceutical and biopharmaceutical applications. 

Spray drying converts liquid formulations into dry powders in a single continuous process. Compared with freeze drying, it offers faster processing times and lower operating costs, making it attractive for large-scale manufacturing. 

However, spray drying typically operates at temperatures above 80°C. While this enables rapid moisture removal, it can present challenges for highly sensitive biologics and temperature-sensitive compounds. 

Despite this, advances in technology have expanded its use beyond traditional food and bulk pharmaceutical applications to include more complex products such as microencapsulated bacteria, nanoparticles, and specialized drug delivery systems. 

How Spray Drying Works 

The liquid formulation is atomized into fine droplets and introduced into a heated drying chamber. As the droplets pass through the chamber, moisture rapidly evaporates, leaving behind a dry powder that is collected for further processing. Because drying occurs continuously, production throughput can be significantly higher than traditional freeze drying methods.